Patents by Inventor Husheng MEI

Husheng MEI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240319169
    Abstract: The present invention provides a cell culture medium for culturing primary gastrointestinal stromal tumor cells, comprising gastrin, N2, insulin, a receptor tyrosine kinase ligand, and a Rock kinase inhibitor. The present invention further provides a method for culturing gastrointestinal stromal tumor cells by using the cell culture medium, and an application and a method of an expanded cell population, which is obtained by using the method, in efficacy evaluation or screening.
    Type: Application
    Filed: January 22, 2021
    Publication date: September 26, 2024
    Applicant: PRECEDO PHARMACEUTICALS CO., LTD
    Inventors: Qingsong LIU, Feiyang LIU, Xiaoyu LI, Husheng MEI, Wenchao WANG, Tao REN, Li WANG
  • Publication number: 20220389379
    Abstract: Provided is a culture medium containing amphiregulin for culturing primary breast epithelial cells and a culture method involving using the medium. In the culturing method, primary cells are cultured on a culture vessel coated with an extracellular matrix gel by using the culture medium, and the primary cells grow on the culture vessel, which has been coated with the extracellular matrix gel, and proliferate rapidly under the combined action of nutrient factors and an extracellular matrix contained in the primary cell culture medium. The cell model obtained by the primary cell culture medium and the primary cell culture method can be used for the evaluating the efficacy of and screening drugs.
    Type: Application
    Filed: November 18, 2019
    Publication date: December 8, 2022
    Applicant: PRECEDO PHARMACEUTICALS CO., LTD
    Inventors: Qingsong LIU, Feiyang LIU, Husheng MEI, Wenchao WANG, Ming ZHAO, Zongru JIANG, Tao REN, Li WANG